GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Cyclically Adjusted PS Ratio

Societal CDMO (FRA:RAH) Cyclically Adjusted PS Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Societal CDMO Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Societal CDMO's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Cyclically Adjusted PS Ratio Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.36 0.32 0.08

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.26 0.24 0.10 0.08

Competitive Comparison of Societal CDMO's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Societal CDMO's Cyclically Adjusted PS Ratio falls into.



Societal CDMO Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Societal CDMO's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Societal CDMO's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.243/129.4194*129.4194
=0.243

Current CPI (Dec. 2023) = 129.4194.

Societal CDMO Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 2.123 100.684 2.729
201509 1.616 100.392 2.083
201512 1.498 99.792 1.943
201603 1.722 100.470 2.218
201606 1.611 101.688 2.050
201609 1.401 101.861 1.780
201612 1.238 101.863 1.573
201703 0.920 102.862 1.158
201706 0.784 103.349 0.982
201709 0.753 104.136 0.936
201712 0.841 104.011 1.046
201803 0.825 105.290 1.014
201806 0.912 106.317 1.110
201809 0.756 106.507 0.919
201812 0.727 105.998 0.888
201903 1.009 107.251 1.218
201906 1.207 108.070 1.445
201909 0.970 108.329 1.159
201912 0.632 108.420 0.754
202003 0.842 108.902 1.001
202006 0.585 108.767 0.696
202009 0.693 109.815 0.817
202012 0.334 109.897 0.393
202103 0.475 111.754 0.550
202106 0.380 114.631 0.429
202109 0.301 115.734 0.337
202112 0.352 117.630 0.387
202203 0.342 121.301 0.365
202206 0.387 125.017 0.401
202209 0.385 125.227 0.398
202212 0.370 125.222 0.382
202303 0.237 127.348 0.241
202306 0.230 128.729 0.231
202309 0.220 129.860 0.219
202312 0.243 129.419 0.243

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Societal CDMO  (FRA:RAH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Societal CDMO Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines